SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-014986
Filing Date
2017-03-16
Accepted
2017-03-16 11:46:11
Documents
72
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v461168_10k.htm 10-K 912041
2 EXHIBIT 23.1 v461168_ex23-1.htm EX-23.1 2356
3 EXHIBIT 31.1 v461168_ex31-1.htm EX-31.1 9720
4 EXHIBIT 32.1 v461168_ex32-1.htm EX-32.1 4385
11 GRAPHIC image_001.jpg GRAPHIC 21492
  Complete submission text file 0001144204-17-014986.txt   5491410

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ttnp-20161231.xml EX-101.INS 1229487
6 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20161231.xsd EX-101.SCH 54672
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20161231_cal.xml EX-101.CAL 36511
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20161231_def.xml EX-101.DEF 288567
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20161231_lab.xml EX-101.LAB 370762
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20161231_pre.xml EX-101.PRE 343387
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 17693515
SIC: 2836 Biological Products, (No Diagnostic Substances)